Using synthetic biology for chlamydia vaccines

A multidisciplinary scientific team at Lawrence Livermore National Laboratory (LLNL) has made significant advances in developing a vaccine for chlamydia using synthetic biology, sponsored by a two-year National Institutes of Health (NIH ) grant. They detail their work in a recent paper published in the Journal of Biochemistry (JBC): "Cell- Free Production of a Functional Oligomeric Form of a Chlamydia Major Outer Membrane Protein (MOMP) for Vaccine Development." This work was performed in partnership with researchers at University of California, Davis and the vaccine group at Synthetic Genomics, Inc .

Using synthetic biology for chlamydia vaccines

A multidisciplinary scientific team at Lawrence Livermore National Laboratory (LLNL) has made significant advances in developing a vaccine for chlamydia using synthetic biology, sponsored by ...

Wed 13 Sep 17 from Phys.org

Chlamydia Vaccine Target of Lawrence Livermore, Synthetic Genomics Work

NewsChlamydia antigens produced through a hyper-targeted method by scientists from Lawrence Livermore National Laboratory and the biotech company Synthetic Genomics could pave the way toward ...

Wed 13 Sep 17 from Laboratory Equipment

  • Pages: 1

Bookmark

Bookmark and Share